Eurepa 2 Tablet is a prescription drug, available for use as Tablet. It is typically used for the treatment of Diabetes Type 2.
The optimal dosage of Eurepa 2 Tablet is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Eurepa 2 Tablet as well, which are listed below. Such side effects of Eurepa 2 Tablet normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
Eurepa 2 Tablet's effect during pregnancy is Severe and Severe while nursing. It is important to know if Eurepa 2 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Eurepa 2 Tablet related warnings section.
Eurepa 2 Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Eurepa 2 Tablet in conditions like Diabetic Ketoacidosis, Diabetes Type 1, Heart Disease. Some other conditions that can be affected by Eurepa 2 Tablet are listed in the contraindications section below.
Drug reaction of Eurepa 2 Tablet with other medicines has been reported. See below for a complete list.
You should also be aware that Eurepa 2 Tablet is safe while driving, and is addiction.
Eurepa 2 Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Based on research, the following side effects have been observed when Eurepa 2 Tablet is used -
Severe
Moderate
Mild
Is the use of Eurepa 2 Tablet safe for pregnant women?
Pregnant women may get severe side effects after taking Eurepa. If you are pregnant, do not take Eurepa without a doctor's advice.
Is the use of Eurepa 2 Tablet safe during breastfeeding?
Taking Eurepa may lead to serious side effects if you are breastfeeding. Eurepa should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Eurepa 2 Tablet on the Kidneys?
Eurepa can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Eurepa 2 Tablet on the Liver?
Eurepa may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Eurepa 2 Tablet on the Heart?
Eurepa has very mild side effects on the heart.
Eurepa 2 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Eurepa 2 Tablet unless your doctor advises you to do so -
Is this Eurepa 2 Tablet habit forming or addictive?
No, you will not get addicted to Eurepa 2 Tablet.
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking Eurepa 2 Tablet as it does not make you drowsy.
Is it safe?
Eurepa 2 Tablet is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, the use of Eurepa 2 Tablet in mental disorders is not effective.
Interaction between Food and Eurepa 2 Tablet
There is no information on the effects of taking Eurepa 2 Tablet with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Eurepa 2 Tablet
Taking Eurepa 2 Tablet with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Prandin® (repaglinide)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 273